Literature DB >> 19078714

Cardiac disease in myasthenia gravis: a literature review.

Maya Guglin1, Joseph V Campellone, Kathleen Heintz, Joseph E Parrillo.   

Abstract

Patients with myasthenia gravis might develop various cardiac disorders, yet a causal relationship remains unestablished. Because causes of sudden death in this population have not been ascertained, further attention to possible cardiac disease in this population is warranted. We summarize the current literature and describe the possible etiologies and implications of cardiac disease in myasthenics.

Entities:  

Year:  2003        PMID: 19078714     DOI: 10.1097/00131402-200306000-00006

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  5 in total

Review 1.  Myasthenic crisis.

Authors:  David Lacomis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis.

Authors:  Giuliano Ohde Dalledone; Gustavo Lenci Marques; Renata Dal-Prá Ducci; Arnaldo Laffitte Stier Junior; Cláudia Suemi Kamoi Kay; Lineu Cesar Werneck; Paulo José Lorenzoni; Rosana Herminia Scola
Journal:  Case Rep Neurol Med       Date:  2016-10-16

3.  Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine.

Authors:  Mohammad Saud Khan; Abhinav Tiwari; Zubair Khan; Himani Sharma; Mohammad Taleb; Jeffrey Hammersley
Journal:  Case Rep Cardiol       Date:  2017-05-14

4.  Pyridostigmine-induced high grade SA-block in a patient with myasthenia gravis.

Authors:  Sarmad Said; Chad J Cooper; Haider Alkhateeb; Sherif Elhanafi; Jorge Bizet; Sucheta Gosavi; Zainul Abedin
Journal:  Am J Case Rep       Date:  2013-09-11

5.  Pyridostigmine induced heart block requiring ICU admission.

Authors:  Benjamin Chaucer; Dustin Whelan; Dronacharya Lamichhane
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.